News

Members of the neurogenomics group presented their work on the 11th European Conference of Comparative Neurobiology

José Manuel Ruiz and Paula Mayo González, members of the neurogenomics group, attended the 11th European Conference of Comparative Neurobiology (ECCN2025) meeting in San Juan,...

Read more

Members of GRIB presented their work at the congress of the European Association for Cancer Research (EACR)

Lilian Marie Boll and Marta Espinosa Camarena presented their work at the congress of the European Association for Cancer Research (EACR)...

Read more

New pathways discovered for drugs to act on cells

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study led by the Hospital del...

Read more

Massive Data Analysis Advances the Understanding of How Immunotherapy Works

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature...

Read more

Science from a neurodivergent perspective

David Aranda, a neurodivergent researcher on GRIB'S Group, talks to us about how his structured way of thinking has become key asset to advance...

Read more

Marta Espinosa, member of the GRIB, attended the first congress of the Spanish Society of Bioinformatics and Computational Biology

Marta Espinosa presented the article "Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort" during...

Read more

Alternative in animal testing: replacing them with virtual ones to sacrifice less

This September, a European project led by the Universitat Pompeu Fabra and where GRIB participates has been launched which aims to replace a quarter...

Read more

Mar Albà, Ferran sanz and Manuel Pastor in the ranking World’s Top 2% Scientist of Stanford’s University

The new edition of the ranking, which has just been published, includes 41 researchers who have worked at Hospital de Mar and the Research...

Read more

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

VICT3R is a new IHI-funded initiative aiming to revolutionize nonclinical safety testing by significantly reducing animal use in toxicology research....

Read more